MapLight Therapeutics, Inc.
MPLT
68 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Oct 16 9:00 PM | Anatol KreitzerChief Discovery Officer | Sale | 12,248 | $7.84 | $96.0K | 168,678(D) | View → |
| Oct 15, 2026 | Oct 16 9:00 PM | Jonathan GillisCAO and Interim CFO | Sale | 10,167 | $8.08 | $82.1K | 142,315(D) | View → |
| Oct 15, 2026 | Oct 16 9:00 PM | James Woodruff LillieChief Scientific Officer | Sale | 11,513 | $8.08 | $93.0K | 198,597(D) | View → |
| Oct 15, 2026 | Oct 16 9:00 PM | Kristopher HansonGeneral Counsel | Sale | 9,020 | $8.08 | $72.9K | 128,024(D) | View → |
| Oct 15, 2026 | Oct 16 9:00 PM | Erin Pennock FoffChief Medical Officer | Sale | 15,355 | $8.08 | $124.1K | 296,906(D) | View → |
| Oct 15, 2026 | Oct 16 9:00 PM | Christopher A. KroegerDirector, Chief Executive Officer | Sale | 73,691 | $8.08 | $595.4K | 1,195,909(D) | View → |
| Oct 15, 2026 | Oct 15 10:35 PM | Hanson Kristopher | Proposed Sale | 9,020 | $7.81 | $70.4K | — | View → |
| Oct 15, 2026 | Oct 15 9:44 PM | GILLIS JONATHAN | Proposed Sale | 10,167 | $7.81 | $79.4K | — | View → |
| Oct 15, 2026 | Oct 15 9:30 PM | Foff Erin Pennock | Proposed Sale | 15,355 | $7.81 | $119.9K | — | View → |
| Oct 15, 2026 | Oct 15 9:26 PM | Kroeger Christopher A. | Proposed Sale | 73,691 | $7.81 | $575.5K | — | View → |
| Oct 15, 2026 | Oct 15 9:15 PM | Lillie James Woodruff | Proposed Sale | 11,513 | $7.81 | $89.9K | — | View → |
| Oct 15, 2026 | Oct 15 8:37 PM | ROBERT MALENKA | Proposed Sale | 14,809 | $7.81 | $115.7K | — | View → |
| Oct 15, 2026 | Oct 15 8:09 PM | Anatol Kreitzer | Proposed Sale | 12,500 | $7.81 | $97.6K | — | View → |
| Sep 16, 2026 | Sep 18 8:15 PM | Kristopher HansonGeneral Counsel | Sale | 16,509 | $11.67 | $192.7K | 137,044(D) | View → |
| Sep 16, 2026 | Sep 16 8:20 PM | Hanson Kristopher | Proposed Sale | 16,509 | $12.08 | $199.4K | — | View → |
| Aug 14, 2026 | Aug 18 10:55 PM | Catalyst4, Inc.10% Owner | Purchase | 4,400,000 | $11.38 | $50.1M | 25,306,689(I) | View → |
| Aug 3, 2026 | Aug 5 12:39 AM | James Woodruff LillieChief Scientific Officer | Sale | 22,082 | $12.54 | $276.9K | 202,380(D) | View → |
| Aug 3, 2026 | Aug 3 8:00 PM | Lillie James Woodruff | Proposed Sale | 22,082 | $13.02 | $287.5K | — | View → |
| Jul 30, 2026 | Jul 31 1:08 AM | Novo Holdings A/S | Proposed Sale | 1,600,000 | $15.02 | $24.0M | — | View → |
| Jul 30, 2026 | Jul 30 10:39 PM | Catalyst4, Inc.10% Owner | Purchase | 1,000,000 | $13.00 | $13.0M | 20,906,689(I) | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 19 10:35 PM | Anatol KreitzerChief Discovery Officer | Grant/Award | 24,455 | $11.25 | 24,455(D) | View → |
| Aug 17, 2026 | Aug 19 10:35 PM | Jonathan GillisCAO and Interim CFO | Grant/Award | 27,268 | $11.25 | 2,813(D) | View → |
| Aug 17, 2026 | Aug 19 10:35 PM | James Woodruff LillieChief Scientific Officer | Grant/Award | 31,395 | $11.25 | 31,395(D) | View → |
| Aug 17, 2026 | Aug 19 10:35 PM | Kristopher HansonGeneral Counsel | Grant/Award | 31,395 | $11.25 | 31,395(D) | View → |
| Aug 17, 2026 | Aug 19 10:35 PM | Erin Pennock FoffChief Medical Officer | Grant/Award | 54,240 | $11.25 | 54,240(D) | View → |
| Aug 17, 2026 | Aug 19 10:35 PM | Christopher A. KroegerDirector, Chief Executive Officer | Grant/Award | 93,955 | $11.25 | 93,955(D) | View → |
| Aug 14, 2026 | Aug 18 10:55 PM | Catalyst4, Inc.10% Owner | Purchase | 2,928,686 | $0.0001 | 2,928,686(I) | View → |
| Jun 23, 2026 | Jun 25 10:04 PM | Troy CoxDirector | Grant/Award | 29,804 | $28.64 | 29,804(D) | View → |
| Jun 23, 2026 | Jun 25 10:01 PM | Martin BablerDirector | Grant/Award | 29,804 | $28.64 | 29,804(D) | View → |
| Jun 23, 2026 | Jun 25 9:59 PM | Timothy John GarnettDirector | Grant/Award | 14,902 | $28.64 | 14,902(D) | View → |
| Jun 23, 2026 | Jun 25 9:57 PM | Nanna Liebach LuneborgDirector | Grant/Award | 14,902 | $28.64 | 14,902(D) | View → |
| Jun 23, 2026 | Jun 25 9:54 PM | George PavlovDirector | Grant/Award | 14,902 | $28.64 | 14,902(D) | View → |
| Jun 23, 2026 | Jun 25 9:52 PM | Maria C WalkerDirector | Grant/Award | 14,902 | $28.64 | 14,902(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Jonathan GillisCAAO and PAO | Grant/Award | 24,455 | $15.70 | 24,455(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Vishwas SetiaChief Financial Officer | Grant/Award | 31,395 | $15.70 | 31,395(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | James Woodruff LillieChief Scientific Officer | Grant/Award | 31,395 | $15.70 | 31,395(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Anatol KreitzerChief Discovery Officer | Grant/Award | 24,455 | $15.70 | 24,455(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Kristopher HansonGeneral Counsel | Grant/Award | 31,395 | $15.70 | 31,395(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Erin Pennock FoffChief Medical Officer | Grant/Award | 54,240 | $15.70 | 54,240(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Christopher A. KroegerDirector, Chief Executive Officer | Grant/Award | 93,955 | $15.70 | 93,955(D) | View → |